Mission
frontal lobe of the brain and may extend back to the temporal lobe. FTD is the second most common early-onset dementia after Alzheimer's disease.
Public Charity
The Bluefield Project to Cure Frontotemporal Dementia
The Bluefield Project to Cure Frontotemporal Dementia is a Public Charity headquartered in San Francisco, CA. Financial data from the 2025 filing: $1.9M revenue, $6.8M expenses, $13.2M total assets. 19 publicly reported grants to this organization, totaling roughly $12.0M, appear in IRS filings.
EIN: 272444495
San Francisco, CA
Brain Disorders
NTEE: G48
Latest filing: 2025
Total Revenue$1.9M
Total Expenses$6.8M
Total Assets$13.2M
Grant Records19
Funding Total$12.0M
Filing Years2021–2025
Where $100 goes at The Bluefield Project to Cure Frontotemporal Dementia
How The Bluefield Project to Cure Frontotemporal Dementia divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.
$95
Programs
the work itself
$5
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $95 for programs
$95
The Bluefield Project is an effort to find a treatment or cure for frontotemporal dementia (FTD) by funding FTD-related research
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL SUPPORT
$8,871
GENERAL SUPPORT
$8,871
UNRESTRICTED
$9,261
GENERAL SUPPORT
$7,281
GENFI RESEARCH CENTER SUPPORT
$290,000
Showing up to 5 of 19 total records — full history available with membership.
Officers & Directors
Dir Research Pship
Alexandra Nicholson
Director
Bruce Miller Md
Secty/Treasurer
Christopher Donohoe
Director
Ian Massey Phd
Director
Karen Chen Phd
President
Laura Mitic
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $1.9M | $6.8M | $13.2M |
| 2024 | $2.3M | $7.5M | $18.3M |
| 2023 | $2.1M | $9.1M | $25.7M |
| 2022 | $2.9M | $7.4M | $29.7M |
| 2021 | $4.4M | $5.0M | $38.0M |
Between 2021 and 2025, reported annual revenue declined from $4.4M to $1.9M (-56%), with total assets most recently reported at $13.2M.
Interactive year-over-year charts and full filing details available with membership.